Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Viking Therapeutics
(VKTX)
NASDAQ
:VKTX
VKTX
Viking Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Viking Therapeutics (VKTX) Stock News & Sentiment
Compare
Follow
7,145
Followers
Premium
Ratings
Strong Enrollment and Promising Strategy Propel Viking Therapeutics to ‘Buy’ Rating
24d ago
VKTX
Premium
Ratings
Promising Potential of Viking Therapeutics’ VK2735 Justifies Buy Rating
24d ago
VKTX
Premium
Market News
Viking Therapeutics Stock (VKTX) Jumps on Obesity Drug. Next Big Pharma Target?
1M ago
NVO
PFE
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
1M ago
B
HD
Premium
Ratings
Viking Therapeutics’ VK2735: A Promising Step Forward in Metabolic Disease Treatment Justifying a Buy Rating
1M ago
VKTX
Premium
Ratings
Viking Therapeutics’ VK2735 Trials and Strategic Positioning Drive Buy Rating
1M ago
VKTX
Premium
Ratings
Promising Potential of Viking Therapeutics’ VK2735: A Buy Rating Justified by Efficacy in Weight Loss and Metabolic Health
1M ago
VKTX
More VKTX News >
VKTX News on the Web
All News
Bearish News
Bullish News
2025-12-12
Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win
Zacks
Neutral
2025-12-12
NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?
Zacks
Neutral
2025-12-11
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
CNBC
Neutral
2025-12-10
Can NVO Defend Its Obesity Lead as GLP-1 Competition Intensifies?
Zacks
Neutral
2025-12-10
PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence
Zacks
Bullish
2025-12-09
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
Zacks
Neutral
2025-12-04
LLY Trading Above 50 & 200-Day SMAs for 2 Months: How to Play the Stock
Zacks
Neutral
2025-12-04
Why Viking Therapeutics, Inc.’s (VKTX) Stock Is Up 8.39%
AAII
Neutral
144
Results | Showing
1
out of
18
News Score - Last 7 Days
Neutral
VKTX
Sector Average
Media Buzz
This Week
6 articles
Weekly Average
6.75 articles
News Sentiment
This Week
100%
Sector Average
57%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is VKTX’s Media Buzz Sentiment?
6 articles about VKTX were published this week. In an average week, 6.75 articles are published.
What is VKTX’s weekly average amount of articles?
In an average week, 6.75 articles about VKTX are published.
What is VKTX’s News Sentiment?
100% of articles about VKTX were positive this week, compared to its sector average of 57%.
Healthcare Stocks that are Trending in the News
XCUR
Exicure
WVE
Wave Life Sciences
STAA
Staar Surgical
KYMR
Kymera Therapeutics
SCLP
Scancell Holdings
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.